Sponsor or institution
Clinical trials and research at Xinqiao Hospital of Chongqing
As of November 12, 2026, Find a Trial lists 15 clinical trials run by Xinqiao Hospital of Chongqing that are recruiting, in China. By phase: Phase 2 (4), Phase 3 (1), Early Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 15Clinical trials
- 1Country
Newest trials
All recruiting trials (15)
-
CD19-targeted mRNA therapy delivered by lipid nanoparticles for B-cell blood cancers
It will try a lipid-nanoparticle mRNA therapy that generates CD19-targeted CAR-T activity inside the body for adults (18–70) with relapsed or refractory CD19-positive B-cell leukemia or lymphoma who have no standard treatment options.
-
IV tenecteplase given before clot removal for large-vessel ischemic stroke in the 4.5–24 hour window
This trial tests whether a single IV dose of tenecteplase given before clot removal helps people with large-vessel ischemic stroke who arrive 4.5–24 hours after they were last well.
-
Optimal combination of radiotherapy schedules and Benmelstobart to induce abscopal responses in metastatic NSCLC
This study will test whether different radiotherapy schedules given with Benmelstobart can cause shrinking of untreated tumors (the abscopal effect) in people with stage IV NSCLC who do not have EGFR/ALK mutations and have multiple metastases.
-
Finding the best organ-targeted radiotherapy plus chemo and PD-1 combinations to trigger abscopal responses in metastatic non-small cell lung cancer without EGFR/ALK mutations
This study will try different combinations of radiotherapy, chemotherapy, and PD‑1 immunotherapy to see if they trigger whole-body (abscopal) tumor responses and improve outcomes for people with metastatic NSCLC who do not have EGFR or ALK mutations.
-
Endovascular treatment for patients with extra-large ischemic stroke
This study is testing if a procedure called thrombectomy can help people with very large strokes caused by blocked blood vessels feel better compared to just getting standard medical care.
-
Thalidomide improves cetuximab and chemotherapy effectiveness for left colorectal cancer
This study is testing if adding thalidomide can make cetuximab and chemotherapy work better for people with advanced left colorectal cancer that can't be surgically removed.
-
Registry for Endovascular Thrombectomy in Extra-Large Stroke Patients
This study is trying to see how well a procedure called endovascular thrombectomy works for people with very large strokes to help improve their outcomes.
-
Hypothermia with endovascular thrombectomy for acute ischemic stroke
This trial tests whether cooling the brain together with mechanical clot removal helps people who had a stroke caused by a blocked large vessel.
-
Minimally invasive procedure for treating brain hemorrhage
This study tests a new, less invasive procedure to see if it can help people with brain bleeding recover better than traditional methods.
-
Evaluating the effectiveness of immunotherapy for advanced cancers
This study is testing how well immunotherapy works for people with advanced cancers like lung, stomach, and breast cancer by collecting and analyzing different types of medical data.
-
Combining advanced radiotherapy with immune therapy for lung cancer
This study is testing a new treatment for advanced lung cancer that combines special radiation therapy with immune therapy to see if it can help patients feel better and improve their outcomes.
-
Using Stereotactic Radiotherapy for Lung Cancer Patients with Stable Disease After Immunotherapy
This study is testing if adding a type of targeted radiation therapy can help lung cancer patients, who have stable disease after immunotherapy, live longer and improve their overall health.
-
Mapping treatment strategies for radiation and immune checkpoint inhibitor pneumonitis using single-cell sequencing
This study is testing how single-cell sequencing can help find better treatments for patients with lung inflammation caused by radiation or immune therapies.
-
Simple non-contrast CT versus advanced imaging to choose thrombectomy for acute large-vessel stroke
This trial tests whether a simple non-contrast CT scan (using ASPECTS) works as well as advanced imaging (CT perfusion or MRI) to decide if people with acute large-vessel ischemic stroke should have thrombectomy.
-
Combining toripalimab with radiotherapy for treating nasopharyngeal carcinoma
This study is testing if combining a new immunotherapy drug called toripalimab with radiotherapy can help people with nasopharyngeal cancer that has spread, and improve their chances of living longer and feeling better.
Quick answers
How many clinical trials run by Xinqiao Hospital of Chongqing are recruiting right now?
15, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 3: 1, Early Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.